Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Seoulin Bioscience Co., Ltd. (038070)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
4,575.
00
-25
-0.5435%
₩
45.63B
Market Cap
-
P/E Ratio
400%
Div Yield
9,075
Volume
-
Eps
₩
4,600
Previous Close
Watching
Watch
Add Transaction
Day Range
4,570
4,650
Year Range
3,600
7,779.64
Want to track
038070
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Seoulin Bioscience Co., Ltd. (038070) Statistics
Valuation metrics
Market Cap
45.63B
Enterprise value
27.2B
Trailing P/E (ttm)
60.82
Forward P/E
-
PEG ratio
-1.05
Price/Sales (ttm)
0.58
Price/Book (mrq)
0.55
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
14.19
Overview
Shares outstanding
8.83M
Float
6.31M
Shares short
-
% Held by insiders
0.28%
% Held by institutions
0%
Average volume (10 days)
425.83K
Average volume (90 days)
175.11K
Price summary
52-Week low
3,600
52-Week high
7,779.64
Beta
0.6
50-Day moving average
6,169
200-Day moving average
6,392.46
Dividends and splits
Forward annual dividend rate
400
Forward annual dividend yield
0.0774%
Trailing annual dividend rate
100
Trailing annual dividend yield
0.0193%
5-Year annual dividend yield
0.92%
Payout ratio
3.23
Dividend Date
5 Jan 2026
Ex-Dividend Date
29 Dec 2025
Last split factor
1.02:1
Last split Date
29 Dec 2025
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.01%
Operating margin
0.01%
Operational effectiveness
Return on assets
0%
Return on equity
0.01%
Income Statement
Revenue (ttm)
78.58B
Revenue per share (ttm)
9,028.61
Quarterly revenue growth (yoy)
0.08%
Gross profit (ttm)
17.2B
EBITDA
2.77B
Net income to common (ttm)
518.17M
Diluted EPS (ttm)
55
Quarterly earnings growth (yoy)
-0.57%
Balance Sheet
Total cash (mrq)
34.82B
Total cash per share (mrq)
3,841.78
Total debt (mrq)
11.88B
Total Debt/Equity (mrq)
13.93
Current ratio (mrq)
2.23%
Book value per share (mrq)
9,414.95
Cash Flow
Cash flow statement
1.36B
Levered free cash flow (LFCF)
6.43B